PI3K/Akt/mTOR Signaling
Research Areas
Products Related to PI3K/Akt/mTOR Signaling(719)
- GC33765Palmitelaidic Acid (9-trans-Hexadecenoic acid)CAS: 10030-73-6Purity: >98.00%
Palmitelaidic Acid (9-trans-Hexadecenoic acid) is a trans isomer of palmitoleic acid and dietary fatty acid that has been found in dairy fat products and various partially hydrogenated oils.
- GC34053SOLENOPSINCAS: 137038-57-4Purity: >98%
Solenopsin is an ATP-competitive AKT inhibitor with IC50 value of 10 μM .
- GC34121CC-115 hydrochlorideCAS: 1300118-55-1Purity: >98.00%
CC-115 hydrochloride is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM and 21 nM, respectively. CC-115 blocks both mTORC1 and mTORC2 signaling.
- GC34909JR-AB2-011CAS: 2411853-34-2Purity: >98.50%
JR-AB2-011 is an improved mTORC2 inhibitor identified through structure-activity relationship (SAR) studies with an IC 50 value of 0.36μM.
- GC350371,3-Dicaffeoylquinic acidCAS: 19870-46-3Purity: >98.50%
1,3-Dicaffeoylquinic acid inhibits the 3' end processing, terminal connection, and disintegration process of HIV-1 integrase, with IC 50 values of 0.35, 0.56, and 0.84μg/ml respectively.
- GC351243α-HydroxymogrolCAS: 1343402-73-2Purity: >98.00%
3α-Hydroxymogrol is a triterpenoid isolated from Siraitia grosvenorii Swingle, acts as a potent AMPK activator, and enhances AMPK phosphorylation.
- GC351625-Iodo-indirubin-3'-monoximeCAS: 331467-03-9Purity: >99.50%
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase, with IC50s of 9, 20 and 25 nM, respectively.
- GC35212A-674563 hydrochlorideCAS: 2070009-66-2Purity: >98.00%
A-674563 hydrochloride is an orally active Akt inhibitor (K i =11nM).
- GC35242ActeinCAS: 18642-44-9Purity: >98.50%
Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo.
- GC35275AKT-IN-3CAS: 2374740-21-1Purity: >98%
AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells.
- GC35327AMPK activator 1CAS: 1152423-98-7Purity: >98.50%
AMPK activator 1 is an AMPK activator extracted from patent WO2013116491A1, compound No.1-75, has an EC50 of <0.1μM.
- GC35395Arnicolide DCAS: 34532-68-8Purity: >98.00%
Arnicolide D is a sesquiterpene lactone isolated from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner.
- GC35580CAL-130 RacemateCAS: 474012-90-3Purity: >98%
CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor.
- GC35651CenisertibCAS: 871357-89-0Purity: >99.50%
Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia.
- GC36193GSK-3β inhibitor 1CAS: 187325-53-7Purity: >98.00%
GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM.
- GC36312Indirubin-3'-monoxime-5-sulphonic acidCAS: 331467-05-1Purity: >98%
Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of CDK1, CDK5, and GSK-3β with IC50s of 5 nM, 7 nM, and 80 nM, respectively.
- GC36313Indirubin-5-sulfonateCAS: 244021-67-8Purity: >98%
Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, and CDK5/p35, respectively. Indirubin-5-sulfonate also shows inhibitory activity against GSK-3β.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC33765 | Palmitelaidic Acid (9-trans-Hexadecenoic acid) | 10030-73-6 | >98.00% | |
Palmitelaidic Acid (9-trans-Hexadecenoic acid) is a trans isomer of palmitoleic acid and dietary fatty acid that has been found in dairy fat products and various partially hydrogenated oils. | ||||
| GC34053 | SOLENOPSIN | 137038-57-4 | >98% | |
Solenopsin is an ATP-competitive AKT inhibitor with IC50 value of 10 μM . | ||||
| GC34121 | CC-115 hydrochloride | 1300118-55-1 | >98.00% | |
CC-115 hydrochloride is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM and 21 nM, respectively. CC-115 blocks both mTORC1 and mTORC2 signaling. | ||||
| GC34909 | JR-AB2-011 | 2411853-34-2 | >98.50% | |
JR-AB2-011 is an improved mTORC2 inhibitor identified through structure-activity relationship (SAR) studies with an IC 50 value of 0.36μM. | ||||
| GC35037 | 1,3-Dicaffeoylquinic acid | 19870-46-3 | >98.50% | |
1,3-Dicaffeoylquinic acid inhibits the 3' end processing, terminal connection, and disintegration process of HIV-1 integrase, with IC 50 values of 0.35, 0.56, and 0.84μg/ml respectively. | ||||
| GC35124 | 3α-Hydroxymogrol | 1343402-73-2 | >98.00% | |
3α-Hydroxymogrol is a triterpenoid isolated from Siraitia grosvenorii Swingle, acts as a potent AMPK activator, and enhances AMPK phosphorylation. | ||||
| GC35162 | 5-Iodo-indirubin-3'-monoxime | 331467-03-9 | >99.50% | |
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase, with IC50s of 9, 20 and 25 nM, respectively. | ||||
| GC35212 | A-674563 hydrochloride | 2070009-66-2 | >98.00% | |
A-674563 hydrochloride is an orally active Akt inhibitor (K i =11nM). | ||||
| GC35242 | Actein | 18642-44-9 | >98.50% | |
Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo. | ||||
| GC35275 | AKT-IN-3 | 2374740-21-1 | >98% | |
AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells. | ||||
| GC35327 | AMPK activator 1 | 1152423-98-7 | >98.50% | |
AMPK activator 1 is an AMPK activator extracted from patent WO2013116491A1, compound No.1-75, has an EC50 of <0.1μM. | ||||
| GC35395 | Arnicolide D | 34532-68-8 | >98.00% | |
Arnicolide D is a sesquiterpene lactone isolated from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner. | ||||
| GC35509 | BGT226 | 915020-55-2 | >98% | |
BGT226 (NVP-BGT226) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ)/mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells. | ||||
| GC35579 | CAL-130 | 1431697-74-3 | >98% | |
CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively. | ||||
| GC35580 | CAL-130 Racemate | 474012-90-3 | >98% | |
CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor. | ||||
| GC35651 | Cenisertib | 871357-89-0 | >99.50% | |
Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia. | ||||
| GC35747 | Crebanine | 25127-29-1 | >99.50% | |
Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. | ||||
| GC36178 | Gomisin J | 66280-25-9 | >99.00% | |
A lignan with diverse biological activities | ||||
| GC36186 | GS-9901 | 1640247-87-5 | >98% | |
GS-9901 is a highly selective and orally active PI3Kδ inhibitor, with an IC50 of 1 nM. | ||||
| GC36190 | GSK-3 inhibitor 1 | 603272-51-1 | >98.00% | |
GSK-3 inhibitor 1 is an inhibitor of GSK-3. | ||||
| GC36193 | GSK-3β inhibitor 1 | 187325-53-7 | >98.00% | |
GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM. | ||||
| GC36312 | Indirubin-3'-monoxime-5-sulphonic acid | 331467-05-1 | >98% | |
Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of CDK1, CDK5, and GSK-3β with IC50s of 5 nM, 7 nM, and 80 nM, respectively. | ||||
| GC36313 | Indirubin-5-sulfonate | 244021-67-8 | >98% | |
Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, and CDK5/p35, respectively. Indirubin-5-sulfonate also shows inhibitory activity against GSK-3β. | ||||
| GC36426 | LAS191954 | 1403947-26-1 | >98% | |
LAS191954 is a potent, selective and orally active PI3Kδ inhibitor for inflammatory diseases treatment, with an IC50 of 2.6 nM. | ||||
